Desipramine (Pertofrane)

A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
Also Known As:
Pertofrane; Norpramin; Apo-Desipramine; Apotex Brand of Desipramine Hydrochloride; Aventis Behring Brand of Desipramine Hydrochloride; Aventis Brand of Desipramine Hydrochloride; Demethylimipramine; Desipramine Hydrochloride; Novartis Brand of Desipramine Hydrochloride; Novo-Desipramine; Novopharm Brand of Desipramine Hydrochloride; Nu-Desipramine; Nu-Pharm Brand of Desipramine Hydrochloride; PMS-Desipramine; Pertofran; Pertrofran; Petylyl; Pharmascience Brand of Desipramine Hydrochloride; Ratiopharm Brand of Desipramine Hydrochloride; Rhône-Poulenc Rorer Brand of Desipramine Hydrochloride; Temmler Brand of Desipramine Hydrochloride; ratio-Desipramine; Hydrochloride, Desipramine; Nu Pharm Brand of Desipramine Hydrochloride; Rhône Poulenc Rorer Brand of Desipramine Hydrochloride; Desmethylimipramine; 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N-methyl-
Networked: 701 relevant articles (65 outcomes, 121 trials/studies) for this Drug, Comments

Relationship Network

Drug Context: Research Results


1. Kubera, Marta: 5 articles (03/2014 - 11/2009)
2. Jan, Chung-Ren: 4 articles (03/2009 - 12/2003)
3. Oliveto, Alison: 4 articles (01/2005 - 01/2002)
4. Wrona, Danuta: 3 articles (03/2014 - 12/2011)
5. Popoli, Maurizio: 3 articles (01/2014 - 03/2003)
6. Qi, Hong: 3 articles (02/2013 - 09/2002)
7. Chen, Hong-Zhuan: 3 articles (02/2013 - 09/2002)
8. Maes, Michael: 3 articles (01/2013 - 11/2009)
9. Grygier, Beata: 3 articles (01/2013 - 11/2009)
10. Budziszewska, Bogusława: 3 articles (01/2013 - 11/2009)

Related Diseases

1. Pain (Aches)
2. Neuralgia (Stump Neuralgia)
3. Panic Disorder (Panic Attack)
4. Cocaine-Related Disorders (Cocaine Addiction)
5. Tics (Tic)

Related Drugs and Biologics

1. Amitriptyline (Elavil)
2. Tricyclic Antidepressive Agents (Tricyclic Antidepressants)
3. Clomipramine (Anafranil)
4. Imipramine (Janimine)
5. Fluoxetine (Prozac)
6. Serotonin (5 Hydroxytryptamine)
7. Nortriptyline (Aventyl)
8. Antidepressive Agents (Antidepressants)
9. Methadone (Dolophine)
10. Cocaine (Cocaine HCl)

Related Therapies and Procedures

1. Analgesia
2. Ligation
3. Oral Administration
4. Aftercare (After-Treatment)
5. Induced Hypothermia

blog comments powered by Disqus
for Pain,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 13919 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$24.95 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$490.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>